dx 9065a has been researched along with fidexaban in 2 studies
| Studies (dx 9065a) | Trials (dx 9065a) | Recent Studies (post-2010) (dx 9065a) | Studies (fidexaban) | Trials (fidexaban) | Recent Studies (post-2010) (fidexaban) |
|---|---|---|---|---|---|
| 92 | 7 | 8 | 21 | 1 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abendschein, DR; Baum, PK; Eisenberg, PR; Light, DR; Martin, DJ; Post, J; Rumennik, G; Sullivan, ME; Vergona, R | 1 |
| Doggrell, SA | 1 |
1 review(s) available for dx 9065a and fidexaban
| Article | Year |
|---|---|
Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Naphthalenes; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes | 2011 |
1 other study(ies) available for dx 9065a and fidexaban
| Article | Year |
|---|---|
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
Topics: Amidines; Animals; Anticoagulants; Antithrombin III; Arthropod Proteins; Coronary Thrombosis; Disease Models, Animal; Female; Intercellular Signaling Peptides and Proteins; Male; Naphthalenes; Peptides; Propionates; Pyridines; Rabbits; Species Specificity; Venous Thrombosis | 2000 |